More articles from MTA I: Sarcoma/Melanoma Posters

You have access
Comparison of ^99mTc-MDP Bone Scintigraphy and ¹⁸F-FDG PET/CT to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma
ByeongHyeon Byeon, Chang-Bae Kong and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1461;
You have access
Survival and Early FDG PET Response to BRAF and MEK Inhibition in Patients with BRAF-mutant Melanoma
Ronald Schmitt, Sarah Kreidler, Deborah Glueck, Rodabe Amaria, Rene Gonzalez, Karl Lewis, Brian Bagrosky, Jennifer Kwak and Phillip Koo

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1463;
You have access
Prediction of Response to Neoadjuvant Chemotherapy in Osteosarcoma using Dual-phase ¹⁸F-FDG PET/CT
ByeongHyeon Byeon, Chang-Bae Kong and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1460;
You have access
Response assessment using [18F]-fluorothymidine-positron emission tomography (FLT-PET) in a phase II trial of axitinib in advanced melanoma
Daniel Graf, Nikhil Khushalani, Austin Miller and Dominick Lamonica

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1685;
You have access
Total lesion glycolysis by ¹⁸F-FDG PET/CT is a reliable predictor of recurrence in cutaneous malignant melanoma
Seung Hyun Son, Sungmin Kang, Ji-hoon Jung, Choon-Young Kim, Do-Hoon Kim, Chae Moon Hong, Shin Young Jeong, Sang-Woo Lee, Byeong-Cheol Ahn and Jaetae Lee

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1684;
You have access
Sensitivity and false negative rate of sentinel lymph node biopsy (SLNB) in malignant melanoma of different parts of the body
Hojjat Ahmadzadehfar, Torsten Hinz, Anja Wierzbicki, Elham Habibi, Jörg Wenzel, Markus Essler, Marianne Muckle, Hans Biersack and Monika Schmid-Wendtner

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1686;
You have access
Significance of multiple nodal basin drainage in patients with truncal melanoma
Hojjat Ahmadzadehfar, Torsten Hinz, Anja Wierzbicki, Elham Habibi, Jörg Wenzel, Marianne Muckle, Hans Biersack, Markus Essler and Monika Schmid-Wendtner

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1687;
You have access
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18F-FDG PET/CT and MRI
Byung Hyun Byun, Chang-Bae Kong, Ilhan Lim, Byung Il Kim, Chang Woon Choi and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1679;
You have access
Predictive value of 18F-FDG dynamic PET/CT, performed during ipilimumab therapy, for treatment response evaluation in stage IV melanoma
Christos Sachpekidis, Jessica Hassel, Uwe Haberkorn and Antonia Dimitrakopoulou-Strauss

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1683;
You have access
FDG-PET/CT and neoadjuvant chemotherapy in bone sarcomas. Correlation with histology and survival
Laurence Champion, Nina Jehanno, Veronique Edeline, Myriam Wartski, Mathieu Gauthé, Slavomir Petras, Camila Nascimento and Jean Louis Alberini

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 1677;

Main menu

User menu

Search

More articles from MTA I: Sarcoma/Melanoma Posters

Pages